Continue Reading Post >

Latest Tweets

Horlicks up for sale as GSK looks to fund $13bn Novartis deal | Business | The Guardian... selling #Horlicks yes..… https://t.co/RZqMeK2Ei7
9th December, 2018
Although the acquisition of #Tesaro bolsters #GSK’s #oncology program with Zejula, GSK is taking a risk by entering… https://t.co/iYUGdIcjyi
7th December, 2018
#GSK slides after buying cancer firm #Tesaro for hefty $5.1 billion. LONDON (Reuters) - #GlaxoSmithKline has agreed… https://t.co/A1Iy1R2roE
7th December, 2018
#moodys changed #GlaxoSmithKline PLCoutlook to #negative from stable and its guaranteed subsidiaries.The change in… https://t.co/AbCNNeRaIN
5th December, 2018
After sellings its #Oncology Portolio at #Novartis few years ago: #GSK Buys #Tesaro For $5 Billion In Dramatic Bet… https://t.co/qkgboQUGmA
5th December, 2018
GSK seeks to boost oncology with acquisition. The deal with US oncology company Tesaro is worth $5.1 billion (£4 b… https://t.co/6I1lqSveFc
5th December, 2018